Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2026-03-01 @ 1:46 PM
Study NCT ID:
NCT03138733
Status:
COMPLETED
Last Update Posted:
2023-11-08
First Post:
2017-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
Sponsor:
Basilea Pharmaceutica
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BPR-CS-009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | FED | View |